Evaluation of an automated clinical decision system with deep learning dose prediction and NTCP model for prostate cancer proton therapy

To evaluate the feasibility of using a deep learning dose prediction approach to identify patients who could benefit most from proton therapy based on the normal tissue complication probability (NTCP) model.